387 related articles for article (PubMed ID: 16095481)
61. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome.
Liu PY; Wu PC; Chen CY; Chen YC
Gen Hosp Psychiatry; 2011; 33(1):84.e5-7. PubMed ID: 21353143
[TBL] [Abstract][Full Text] [Related]
62. Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia.
Aboraya A; Schumacher J; Abdalla E; LePage J; McGhee M; Butcher D; Griffin H; Shahda M
W V Med J; 2002; 98(2):63-5. PubMed ID: 12048741
[TBL] [Abstract][Full Text] [Related]
63. Neuroleptic malignant syndrome associated with atypical antipsychotics: A case report.
Mogollon Díaz JP; Lizcano Toloza LY; Serrano García AY; Alquichire Luna CA; García Bohorquez DF; Chaparro Durán MF; Cáceres Valero MV
Rev Colomb Psiquiatr (Engl Ed); 2023; 52(1):78-81. PubMed ID: 37031016
[TBL] [Abstract][Full Text] [Related]
64. [Life threatening neuroleptic malignant syndrome due to olanzapine].
Kopf A; Köster J; Schulz A; Krömker H; Becker T
Psychiatr Prax; 2003 Jul; 30(5):279-82. PubMed ID: 12872187
[TBL] [Abstract][Full Text] [Related]
65. Atypical neuroleptic malignant syndrome in H1N1 pneumonia.
Crosby D; Peterson J; Carroll BT
Ann Clin Psychiatry; 2013 Feb; 25(1):69-70. PubMed ID: 23376873
[No Abstract] [Full Text] [Related]
66. An atypical case of neuroleptic malignant syndrome precipitated by valproate.
Verma R; Junewar V; Rathaur BP
BMJ Case Rep; 2014 Mar; 2014():. PubMed ID: 24604797
[TBL] [Abstract][Full Text] [Related]
67. Office-based General Anesthesia for a Patient With a History of Neuroleptic Malignant Syndrome.
Messieha ZS
Anesth Prog; 2023 Mar; 70(1):20-24. PubMed ID: 36995955
[TBL] [Abstract][Full Text] [Related]
68. Neuroleptic malignant syndrome associated with atypical antipsychotic drugs.
Trollor JN; Chen X; Sachdev PS
CNS Drugs; 2009; 23(6):477-92. PubMed ID: 19480467
[TBL] [Abstract][Full Text] [Related]
69. Neuroleptic malignant syndrome following autologous peripheral blood stem cell transplantation.
Garrido SM; Chauncey TR
Bone Marrow Transplant; 1998 Feb; 21(4):427-8. PubMed ID: 9509981
[TBL] [Abstract][Full Text] [Related]
70. Case Report: Ziprasidone induced neuroleptic malignant syndrome.
Sedhai YR; Atreya A; Phuyal P; Basnyat S; Pokhrel S
F1000Res; 2021; 10():124. PubMed ID: 33763203
[TBL] [Abstract][Full Text] [Related]
71. [The application of electroconvulsive therapy in neuroleptic malignant syndrome treatment in patient with catatonic schizophrenia].
Kucia K; Warchala A
Wiad Lek; 2005; 58(9-10):572-4. PubMed ID: 16529073
[TBL] [Abstract][Full Text] [Related]
72. Neuroleptic malignant syndrome with abnormally elevated cardiac troponin I: a case report.
Wang Q; Shi J; Zhao P; Cao Q; Yao Z
J Int Med Res; 2020 Nov; 48(11):300060520968344. PubMed ID: 33203271
[TBL] [Abstract][Full Text] [Related]
73. [Prolonged neuroleptic malignant syndrome after Haloperidol injection].
Wystub N; Heymel S; Fritzenwanger M; Schulze PC; Pfeifer R
Med Klin Intensivmed Notfmed; 2018 Apr; 113(3):212-216. PubMed ID: 28752347
[TBL] [Abstract][Full Text] [Related]
74. [Neuroleptic malignant syndrome: case report with recurrence associated with the use of olanzapine].
Hanel RA; Sandmann MC; Kranich M; De Bittencourt PR
Arq Neuropsiquiatr; 1998 Dec; 56(4):833-7. PubMed ID: 10029891
[TBL] [Abstract][Full Text] [Related]
75. Risperidone-induced neuroleptic malignant syndrome.
Sharma R; Trappler B; Ng YK; Leeman CP
Ann Pharmacother; 1996; 30(7-8):775-8. PubMed ID: 8826559
[TBL] [Abstract][Full Text] [Related]
76. NMS after clozapine initiation.
Skarpathiotakis M; Westreich N
J Am Acad Child Adolesc Psychiatry; 2005 Nov; 44(11):1101-2. PubMed ID: 16239854
[No Abstract] [Full Text] [Related]
77. Response to benzodiazepines and the clinical course in malignant catatonia associated with schizophrenia: A case report.
Ohi K; Kuwata A; Shimada T; Yasuyama T; Nitta Y; Uehara T; Kawasaki Y
Medicine (Baltimore); 2017 Apr; 96(16):e6566. PubMed ID: 28422845
[TBL] [Abstract][Full Text] [Related]
78. Suspected neuroleptic malignant syndrome in a patient receiving clozapine.
Ganelin L; Lichtenberg PS; Marcus EL; Munter RG
Ann Pharmacother; 1996 Mar; 30(3):248-50. PubMed ID: 8833560
[TBL] [Abstract][Full Text] [Related]
79. Neuroleptic malignant syndrome: a case report.
Fekadu A; Wakwoya A
Ethiop Med J; 1999 Jul; 37(3):195-8. PubMed ID: 11957317
[TBL] [Abstract][Full Text] [Related]
80. Neuroleptic malignant syndrome: life-threatening complication of neuroleptic treatment in adolescents with affective disorder.
Joshi PT; Capozzoli JA; Coyle JT
Pediatrics; 1991 Feb; 87(2):235-9. PubMed ID: 1670966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
